Dachaigh › Lupus › North Carolina
Sgrùdaidhean clionaigeach Lupus ann an North Carolina
Tha 20 sgrùdaidhean airson Lupus a’ lorg phàirtichean aig làraichean ann an North Carolina.
Bailtean ann an North Carolina
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50238, Charlotte
A’ fastadhÌre 3
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- DJL Clinical Research, PLLC, Charlotte
- Cross Creek Medical Clinic, PA, Fayetteville
A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Durham
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Joint and Muscle Research Institute, Charlotte
- DJL Clinical Research, PLLC, Charlotte
- Cross Creek Medical Clinic, Fayetteville
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07438496Anifrolumab Pregnancy Study
- Research Site, Cary
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 130 · Banairean · Air ùrachadh 18 Sult 2026 · NCT07049653A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Chapel Hill
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06916806A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Arthritis and Osteoporosis Consultants of the Carolinas II, LLC, Charlotte
- Superior Clinical Research, LLC, Smithfield
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Cross Creek Medical Clinic, Fayetteville
A’ fastadhÌre 2
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, Chapel Hill
- Research Site, Charlotte
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- DJL Clinical Research, PLLC, Charlotte
A’ fastadhSgrùdadh amharc
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07175285Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Research Site, Wilmington
A’ fastadhSgrùdadh amharc
Gach aois · Banairean · Air ùrachadh 2 Sult 2026 · NCT06659029A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of North Carolina TraCS Institute - CTRC, Chapel Hill
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297Intervention to Improve Communication and Medication Adherence in Lupus
- Duke University, Durham
A’ fastadh
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06458075A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
A’ fastadhÌre 1
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- UNC Chapel Hill, Chapel Hill
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT05934149Duke Lupus Registry
- Duke University Medical Center, Durham
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT00512694Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Banairean · Air ùrachadh 8 Faoi 2026 · NCT03276923Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.